- Live moderated video webcast event on Tuesday, December 6th at 11:00 AM ET -
FRENCHTOWN, NJ / ACCESSWIRE / December 5, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor "Ask the CEO" Event with John Climaco, Chief Executive Officer of CNS Pharmaceuticals, on Tuesday, December 6, 2022 at 11:00 AM ET. Access the event here.
CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer.
As part of the virtual event, Mr. Climaco will provide a brief presentation, followed by an interactive Q&A session. This "Ask the CEO" event is intended to provide the investment community direct access to ask their questions directly to Mr. Climaco. Questions can be typed in live during the event or pre-submitted by sending to cnsp@jtcir.com. Mr. Climaco will answer as many questions as possible during the event.
A live video webcast of the Virtual Investor "Ask the CEO" Event featuring CNS Pharmaceuticals will be available on virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
Contact:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
View source version on accesswire.com:https://www.accesswire.com/730184/JTC-Team-to-Host-the-Virtual-Investor-Ask-the-CEO-Event-Featuring-CNS-Pharmaceuticals
